NDC 68727-900

Rylaze

Asparaginase Erwinia Chrysanthemi (recombinant)-rywn

Rylaze is a Intramuscular Injection in the Human Prescription Drug category. It is labeled and distributed by Jazz Pharmaceuticals, Inc.. The primary component is Asparaginase.

• Product ID: 68727-900_19a01d9d-35ce-49dc-a2c9-958a1db5f895
• NDC: 68727-900
• Product Type: Human Prescription Drug
• Proprietary Name: Rylaze
• Generic Name: Asparaginase Erwinia Chrysanthemi (recombinant)-rywn
• Dosage Form: Injection
• Route of Administration: INTRAMUSCULAR
• Marketing Start Date: 2021-06-30
• Marketing Category: BLA /
• Application Number: BLA761179
• Labeler Name: Jazz Pharmaceuticals, Inc.
• Substance Name: ASPARAGINASE
• Active Ingredient Strength: 20 mg/mL
• Pharm Classes: Asparaginase [CS], Asparagine-specific Enzyme [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 68727-900-03

3 VIAL, SINGLE-DOSE in 1 CARTON (68727-900-03) > .5 mL in 1 VIAL, SINGLE-DOSE (68727-900-01)

• Marketing Start Date: 2021-06-30
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details